We make products and services that we’d trust for our own families
At Abbott, quality isn’t just a process—it’s a promise. We make medicines and products we’d trust for our own families, guided by a legacy of over 135 years of experience and a deep commitment to safety, consistency, and care.
Biosimilars undergo rigorous testing through clinical trials to ensure they deliver the same clinical benefits as the reference biologic.
Biosimilars are evaluated and approved by the same trusted regulators as reference biologics, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
Both the FDA and EMA have confirmed that patients and healthcare providers can rely on biosimilars to be as safe and effective as the reference biologic.
At Abbott, we operate with rigorous, industry-leading processes that align with international regulatory standards. Our dedication to quality goes beyond compliance – we are committed to delivering medicines of the highest standard.
To uphold this commitment, we implement additional quality assurance measures, including regular audits of our suppliers. These assessments ensure that our partners maintain the same high standards and adhere to all relevant regulations, reinforcing the integrity of our entire supply chain.
We also have a unique three-tier audit system in which our sites undergo audits from our local, division, and global teams, to ensure the highest quality of our medicines and ensure all the latest quality upgrades are incorporated.
GLO2358835
